Gilder Gagnon Howe & CO LLC Invitae Corp Transaction History

Gilder Gagnon Howe & CO LLC

$8.56 Billion
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.6 - $1.53 $33 - $85	-56 Reduced 0.06%	99,813 $59,000
Q2 2023 Aug 14, 2023	SELL	$1.05 - $1.63 $536,727 - $833,205	-511,169 Reduced 83.66%	99,869 $112,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.73 $1.08 Million - $2.46 Million	-901,253 Reduced 59.6%	611,038 $824,000
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $922,678 - $1.95 Million	-539,578 Reduced 26.3%	1,512,291 $2.81 Million
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $958,540 - $4.35 Million	-504,495 Reduced 19.73%	2,051,869 $5.05 Million
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $1.84 Million - $7.78 Million	-863,102 Reduced 25.24%	2,556,364 $6.24 Million
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $2.39 Million - $5.93 Million	-380,453 Reduced 10.01%	3,419,466 $27.3 Million
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $43.3 Million - $84.4 Million	-2,943,357 Reduced 43.65%	3,799,919 $58 Million
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $1.05 Million - $1.45 Million	-43,273 Reduced 0.64%	6,743,276 $192 Million
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $4.99 Million - $7.72 Million	-191,142 Reduced 2.74%	6,786,549 $229 Million
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $1.2 Million - $2.07 Million	-36,302 Reduced 0.52%	6,977,691 $267 Million
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $3.03 Million - $4.44 Million	-77,393 Reduced 1.09%	7,013,993 $293 Million
Q3 2020 Nov 16, 2020	SELL	$28.43 - $44.67 $5.63 Million - $8.84 Million	-197,974 Reduced 2.72%	7,091,386 $307 Million
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $11.5 Million - $29.7 Million	979,097 Added 15.52%	7,289,360 $221 Million
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $11.4 Million - $40.9 Million	1,488,286 Added 30.86%	6,310,263 $86.3 Million
Q4 2019 Feb 14, 2020	SELL	$15.02 - $20.57 $1.65 Million - $2.26 Million	-109,939 Reduced 2.23%	4,821,977 $77.8 Million
Q3 2019 Nov 14, 2019	SELL	$18.85 - $27.5 $5.31 Million - $7.74 Million	-281,550 Reduced 5.4%	4,931,916 $95 Million
Q2 2019 Aug 13, 2019	SELL	$17.37 - $26.27 $5.5 Million - $8.32 Million	-316,571 Reduced 5.72%	5,213,466 $123 Million
Q1 2019 May 17, 2019	BUY	$10.65 - $25.75 $6.09 Million - $14.7 Million	572,234 Added 11.54%	5,530,037 $130 Million
Q4 2018 Feb 14, 2019	BUY	$9.26 - $16.38 $7.81 Million - $13.8 Million	842,977 Added 20.49%	4,957,803 $54.8 Million
Q3 2018 Oct 30, 2018	BUY	$7.54 - $18.31 $31 Million - $75.3 Million	4,114,826 New	4,114,826 $68.8 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

1.92M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Account